David A. Jude

413 total citations
7 papers, 299 citations indexed

About

David A. Jude is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, David A. Jude has authored 7 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in David A. Jude's work include Asymmetric Synthesis and Catalysis (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and DNA and Nucleic Acid Chemistry (1 paper). David A. Jude is often cited by papers focused on Asymmetric Synthesis and Catalysis (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and DNA and Nucleic Acid Chemistry (1 paper). David A. Jude collaborates with scholars based in United Kingdom. David A. Jude's co-authors include Wright W. Nichols, Gareth M. Davies, Neil J. Hales, Keith Barrett‐Bee, W. J. Watkins, Roger Camble, Richard A. Pauptit, Walter H.J. Ward, Ian W. Taylor and Geoffrey A. Holdgate and has published in prestigious journals such as Biochemistry, Antimicrobial Agents and Chemotherapy and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

David A. Jude

7 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Jude United Kingdom 6 172 109 55 46 41 7 299
Michael N. Lombardo United States 10 136 0.8× 82 0.8× 96 1.7× 31 0.7× 17 0.4× 17 327
Tushar Shakya Canada 8 193 1.1× 80 0.7× 54 1.0× 27 0.6× 14 0.3× 9 303
Moriah M. Gagnon United States 5 156 0.9× 106 1.0× 42 0.8× 12 0.3× 24 0.6× 5 326
Bolin Geng United States 11 217 1.3× 254 2.3× 53 1.0× 34 0.7× 26 0.6× 12 457
Maiko Iida Japan 13 185 1.1× 208 1.9× 39 0.7× 17 0.4× 83 2.0× 23 401
Kenneth A. Newlander United States 10 268 1.6× 356 3.3× 73 1.3× 30 0.7× 124 3.0× 14 537
Usa Reilly United States 8 141 0.8× 182 1.7× 24 0.4× 29 0.6× 25 0.6× 9 460
Logan D. Andrews United States 10 190 1.1× 35 0.3× 36 0.7× 36 0.8× 18 0.4× 11 331
Michele Sugantino United States 5 272 1.6× 123 1.1× 173 3.1× 89 1.9× 28 0.7× 5 445
Stephanie M. Reeve United States 11 141 0.8× 66 0.6× 74 1.3× 23 0.5× 11 0.3× 18 290

Countries citing papers authored by David A. Jude

Since Specialization
Citations

This map shows the geographic impact of David A. Jude's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Jude with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Jude more than expected).

Fields of papers citing papers by David A. Jude

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Jude. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Jude. The network helps show where David A. Jude may publish in the future.

Co-authorship network of co-authors of David A. Jude

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Jude. A scholar is included among the top collaborators of David A. Jude based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Jude. David A. Jude is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Bradbury, Robert H., Neil J. Hales, Alfred A. Rabow, et al.. (2011). Small-molecule androgen receptor downregulators as an approach to treatment of advanced prostate cancer. Bioorganic & Medicinal Chemistry Letters. 21(18). 5442–5445. 36 indexed citations
2.
Ward, Walter H.J., Geoffrey A. Holdgate, Siân Rowsell, et al.. (1999). Kinetic and Structural Characteristics of the Inhibition of Enoyl (Acyl Carrier Protein) Reductase by Triclosan. Biochemistry. 38(38). 12514–12525. 141 indexed citations
3.
Jude, David A., et al.. (1996). Transport of the antibacterial agent (6S)-6-fluoroshikimate and other shikimate analogues by the shikimate transport system of Escherichia coli. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1279(2). 125–129. 8 indexed citations
4.
Adams, Harry, Neil A. Bailey, Martyn Frederickson, et al.. (1996). On the stereochemical outcome of the reaction between (–)-chorismic acid and diazomethane: absolute proof of stereochemistry of the major pyrazoline by X-ray crystallography of a cyclopropane based derivative. Journal of the Chemical Society Perkin Transactions 1. 1531–1533. 1 indexed citations
5.
Jude, David A., et al.. (1995). Frequency and mechanism of resistance to antibacterial action of ZM 240401, (6S)-6-fluoro-shikimic acid. Antimicrobial Agents and Chemotherapy. 39(1). 87–93. 13 indexed citations
6.
Davies, Gareth M., et al.. (1994). (6S)-6-fluoroshikimic acid, an antibacterial agent acting on the aromatic biosynthetic pathway. Antimicrobial Agents and Chemotherapy. 38(2). 403–406. 94 indexed citations
7.
Nolan, Robert D. & David A. Jude. (1983). The infections of [14C]cefotetan with penicillin binding proteins of a wide variety of Gram-positive and Gram-negative species. Journal of Antimicrobial Chemotherapy. 11(suppl A). 169–177. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026